First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent
Clinical trial NCT05413668 · COMPLETED
Trial details
- NCT number
- NCT05413668
- Sponsor
- Reveal Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2022-07-22
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.